the latest news from Biohubx

Together, let's bridge the gap between brilliant innovation and a viable company. Get the latest news, innovations, and information from Biohubx and our partner organizations.

Innovation Launches Here

Calgary, Alberta | It’s been a year in the making, and Alberta’s Biohubx is ready for take-off. The organization, which offers flexible lab and office space and supports to help life science companies commercialize, has this week launched its full website at biohubx.com.

Ground-breaking laboratory ‘hub’ will catalyze life science industry in Calgary

Calgary, AB – Thanks to over $1.4 million in federal funding from Western Economic Diversification Canada, biotech companies have a new home in northwest Calgary with the launch of Biospace1, a lab facility established to support early-stage life science companies through vulnerable scale-up and expansion phases.

the latest blogs from Biohubx

Together, let's bridge the gap between brilliant innovation and a viable company. Get the latest blogs, innovations, and information from Biohubx and our partner organizations.

Not to be Overlooked: Cytotoxicity Testing of Biomaterials and Medical Devices

Biomaterials are materials used in medical devices, and cytotoxicity testing is performed on biomaterials to see how they affect mammalian cells. This is important to test because biomaterials can cause cell death and lead to inflammatory responses if not tested properly. If a biomaterial doesn't meet the standard, additional testing is required. ‍

Biomaterial Genotoxicity Assessment

When developing medical devices and other biomaterials, it's critical to determine how the material will interact with human cells. Genotoxicity tests like the Ames test measure the potential of a biomaterial to cause genetic damage in human cells. If modified bacteria grow on the plates without nutrients, then a genetic mutation has occurred and it's a genotoxic biomaterial. If not, the biomaterial is safe.